Activation of the farnesoid X receptor improves lipid metabolism in combined hyperlipidemic hamsters

American Journal of Physiology - Endocrinology and Metabolism

Volumn 290, Issue 4, 2006, Pages

  Bilz, Stefan ^a   Samuel, Varman ^a   Morino, Katsutaro ^a   Savage, David ^a   Cheol, Soo Choi ^a   Shulman, Gerald I ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chenodeoxycholic acid; Lipogenesis; Triglycerides

Indexed keywords

CHENODEOXYCHOLIC ACID; FARNESOID X RECEPTOR; FATTY ACID SYNTHASE; FRUCTOSE; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; ACYL COENZYME A DESATURASE; CELL RECEPTOR; CHOLESTEROL; CHOLESTEROL 7ALPHA MONOOXYGENASE; DNA BINDING PROTEIN; FARNESOID X-ACTIVATED RECEPTOR; MESSENGER RNA; TRANSCRIPTION FACTOR;

ANIMAL MODEL; ARTICLE; DIET; GENE EXPRESSION; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIPID METABOLISM; LIPOGENESIS; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; LIVER; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; NONHUMAN; PRIORITY JOURNAL; SYRIAN HAMSTER; ANIMAL; BIOSYNTHESIS; BLOOD; DRUG EFFECT; ENZYMOLOGY; GENETICS; HAMSTER; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CHENODEOXYCHOLIC ACID; CHOLESTEROL; CHOLESTEROL 7-ALPHA-HYDROXYLASE; CRICETINAE; DNA-BINDING PROTEINS; FATTY ACID SYNTHETASE COMPLEX; HYPERLIPIDEMIAS; LIPID METABOLISM; LIPOPROTEINS; LIVER; MALE; MESOCRICETUS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEAROYL-COA DESATURASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTORS; TRIGLYCERIDES;

EID: 33646088382     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00355.2005     Document Type: Article

References (40)

1. Albers JJ and Cheung MC. Emerging roles for phospholipid transfer protein in lipid and lipoprotein metabolism. Curr Opin Lipidol 15: 255-260, 2004.
2. Angelin B, Einarsson K, Hellstrom K, and Leijd B. Effects of cholestyramine and chenodeoxycholic acid on the metabolism of endogenous triglyceride in hyperlipoproteinemia. J Lipid Res 19: 1017-1024, 1978.
3. Angelin B, Hershon KS, and Brunzell JD. Bile acid metabolism in hereditary forms of hypertriglyceridemia: evidence for an increased synthesis rate in monogenic familial hypertriglyceridemia. Proc Natl Acad Sci USA 84: 5434-5438, 1987.
4. Bateson MC. Chenodeoxycholic acid for hypertriglyceridaemia. Lancet 2: 962-963, 1976.
5. Casaschi A, Maiyoh GK, Adeli K, and Theriault AG. Increased diacylglycerol acyltransferase activity is associated with triglyceride accumulation in tissues of diet-induced insulin-resistant hyperlipidemic hamsters. Metabolism 54: 403-409, 2005.
6. Chen G, Liang G, Ou J, Goldstein JL, and Brown MS. Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc Natl Acad Sci USA 101: 11245-11250, 2004.
7. Claudel T, Inoue Y, Barbier O, Duran-Sandoval D, Kosykh V, Fruchart J, Fruchart JC, Gonzalez FJ, and Staels B. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression. Gastroenterology 125: 544-555, 2003.
8. Claudel T, Sturm E, Duez H, Torra IP, Sirvent A, Kosykh V, Fruchart JC, Dallongeville J, Hum DW, Kuipers F, and Staels B. Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element. J Clin Invest 109: 961-971, 2002.
9. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, and Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 115: 1343-1351, 2005.
10. Duran-Sandoval D, Cariou B, Percevault F, Hennuyer N, Grefhorst A, van Dijk TH, Gonzalez FJ, Fruchart JC, Kuipers F, and Staels B. The farnesoid X receptor modulates hepatic carbohydrate metabolism during fasting/refeeding transition. J Biol Chem 280: 29971-29979, 2005.
11. Duran-Sandoval D, Mautino G, Martin G, Percevault F, Barbier O, Fruchart JC, Kuipers F, and Staels B. Glucose regulates the expression of the farnesoid X receptor in liver. Diabetes 53: 890-898, 2004.
12. Forcheron F, Cachefo A, Thevenon S, Pinteur C, and Beylot M. Mechanisms of the triglyceride- and cholesterol-lowering effect of feno-fibrate in hyperlipidemic type 2 diabetic patients. Diabetes 51: 3486-3491, 2002.
13. Goodwin B, Jones SA, Price RR, Watson MA, McKee DD, Moore LB, Galardi C, Wilson JG, Lewis MC, Roth ME, Maloney PR, Willson TM, and Kliewer SA. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell 6: 517-526, 2000.
14. Hirokane H, Nakahara M, Tachibana S, Shimizu M, and Sato R. Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4. J Biol Chem 279: 45685-45692, 2004.
15. Ishii S, Iizuka K, Miller BC, and Uyeda K. Carbohydrate response element binding protein directly promotes lipogenic enzyme gene transcription. Proc Natl Acad Sci USA 101: 15597-15602, 2004.
16. Jiang XC, Bruce C, Mar J, Lin M, Ji Y, Francone OL, and Tall AR. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest 103: 907-914, 1999.
17. Joseph SB, Laffitte BA, Patel PH, Watson MA, Matsukuma KE, Walczak R, Collins JL, Osborne TF, and Tontonoz P. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. J Biol Chem 277: 11019-11025, 2002.
18. Leiss O and von Bergmann K. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones. Scand J Gastroenterol 17: 587-592, 1982.
19. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, and Shan B. Identification of a nuclear receptor for bile acids. Science 284: 1362-1365, 1999.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, and Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
21. Miller NE and Nestel PJ. Triglyceride-lowering effect of chenodeoxycholic acid in patients with endogenous hypertriglyceridaemia. Lancet 2: 929-931, 1974.
22. Muller PY, Janovjak H, Miserez AR, and Dobbie Z. Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32: 1372-1379, 2002.
23. Nakahara M, Fujii H, Maloney PR, Shimizu M, and Sato R. Bile acids enhance low density lipoprotein receptor gene expression via a MAPK cascade-mediated stabilization of mRNA. J Biol Chem 277: 37229-37234, 2002.
24. Otway S and Robinson DS. The use of a non-ionic detergent (Triton WR 1339) to determine rates of triglyceride entry into the circulation of the rat under different physiological conditions. J Physiol 190: 321-332, 1967.
25. Pease RJ and Leiper JM. Regulation of hepatic apolipoprotein-B-containing lipoprotein secretion. Curr Opin Lipidol 7: 132-138, 1996.
26. Pineda Torra, I, Claudel T, Duval C, Kosykh V, Fruchart JC, and Staels B. Bile acids induce the expression of the human peroxisome proliferator-activated receptor alpha gene via activation of the farnesoid X receptor. Mol Endocrinol 17: 259-272, 2003.
27. Samuel VT, Liu ZX, Qu X, Elder BD, Bilz S, Befroy D, Romanelli AJ, and Shulman GI. Mechanism of hepatic insulin resistance in nonalcoholic fatty liver disease. J Biol Chem 279: 32345-32353, 2004.
28. Schultz JR, Tu H, Luk A, Repa JJ, Medina JC, Li L, Schwendner S, Wang S, Thoolen M, Mangelsdorf DJ, Lustig KD, and Shan B. Role of LXRs in control of lipogenesis. Genes Dev 14: 2831-2838, 2000.
29. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, and Goldstein JL. Decreased IRS-2 and increased Srebp-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6: 77-86, 2000.
30. Sinal CJ, Tohkin M, Miyata M, Ward JM, Lambert G, and Gonzalez FJ. Targeted disruption of the nuclear receptor FXR/BAR impairs bile acid and lipid homeostasis. Cell 102: 731-744, 2000.
31. Sirvent A, Claudel T, Martin G, Brozek J, Kosykh V, Darteil R, Hum DW, Fruchart JC, and Staels B. The farnesoid X receptor induces very low density lipoprotein receptor gene expression. FEBS Lett 566: 173-177, 2004.
32. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, and Fruchart JC. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98: 2088-2093, 1998.
33. Taghibiglou C, Carpentier A, Van Iderstine SC, Chen B, Rudy D, Aiton A, Lewis GF, and Adeli K. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J Biol Chem 275: 8416-8425, 2000.
34. Taghibiglou C, Rashid-Kolvear F, Van Iderstine SC, Le Tien H, Fantus IG, Lewis GF, and Adeli K. Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J Biol Chem 277: 793-803, 2002.
35. Urizar NL, Dowhan DH, and Moore DD. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression. J Biol Chem 275: 39313-39317, 2000.
36. Watanabe M, Houten SM, Wang L, Moschetta A, Mangelsdorf DJ, Heyman RA, Moore DD, and Auwerx J. Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and Srebp-1c. J Clin Invest 113: 1408-1418, 2004.
37. Yamagata K, Daitoku H, Shimamoto Y, Matsuzaki H, Hirota K, Ishida J, and Fukamizu A. Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1. J Biol Chem 279: 23158-23165, 2004.
38. Yamashita H, Takenoshita M, Sakurai M, Bruick RK, Henzel WJ, Shillinglaw W, Arnot D, and Uyeda K. A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver. Proc Natl Acad Sci USA 98: 9116-9121, 2001.
39. Yu L, Gupta S, Xu F, Liverman ADB, Moschetta A, Mangelsdorf DJ, Repa JJ, Hobbs HH, and Cohen JC. Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion. J Biol Chem 280: 8742-8747, 2005.
40. Zhang Y, Castellani LW, Sinal CJ, Gonzalez FJ, and Edwards PA. Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev 18: 157-169, 2004.